“Nearly half of the U.S. adult population suffers from periodontitis, a form of chronic gum disease. Bacteria are responsible causing inflammation and eventually bone loss, and in the worst cases, even affecting overall health.
A treatment for this prevalent disease could benefit millions of people. With a recent finding, researchers George Hajishengallis of Penn’s School of Dental Medicine and John Lambris of the Perelman School of Medicine, along with other University colleagues, have made a significant stride toward that goal. In a study published in the Journal of Immunology, they identified a molecular target that, if blocked, hamstrings the inflammatory activity of gum-disease causing bacteria.”
Click here for entire article.